In fact, this had been elegantly demonstrated through the preferential expression of HIF-1α in peri-necrotic/peri-fibrotic tumor cells in TNBC and BRCA1 mutated breast cancers[10,39]. This evidence concerns the gene HIF1A and breast carcinoma.